Juvenile myelomonocytic leukemia (JMML) is a rare clonal hematopoietic disorder of early childhood with features characteristic of both myelodysplastic and myeloproliferative disorders. Recent studies have shown that abnormal proliferation is due to aberrant signal transduction resulting from mutations in components of the RAS-signaling pathway.
Category
Cancer
Brite
Human diseases in ICD-11 classification [BR:br08403]
02 Neoplasms
Neoplasms of haematopoietic or lymphoid tissues
Myelodysplastic and myeloproliferative neoplasms
2A42 Juvenile myelomonocytic leukaemia
H02541 Juvenile myelomonocytic leukemia
Pathway-based classification of diseases [BR:br08402]
Signal transduction
nt06526 MAPK signaling
H02541 Juvenile myelomonocytic leukemia
Cellular process
nt06535 Efferocytosis
H02541 Juvenile myelomonocytic leukemia
Borkhardt A, Bojesen S, Haas OA, Fuchs U, Bartelheimer D, Loncarevic IF, Bohle RM, Harbott J, Repp R, Jaeger U, Viehmann S, Henn T, Korth P, Scharr D, Lampert F
Title
The human GRAF gene is fused to MLL in a unique t(5;11)(q31;q23) and both alleles are disrupted in three cases of myelodysplastic syndrome/acute myeloid leukemia with a deletion 5q.
